Please provide your email address to receive an email when new articles are posted on . Patients were treated with intravenous ertapenem for an average of 13.1 weeks. During a 7-week, posttherapy ...
Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA ...
Please provide your email address to receive an email when new articles are posted on . A trial that evaluated three alternative treatments for anogenital gonorrhea found that a single dose of ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of Ertapenem for Injection in a 1 gram vial presentation. The new product is the generic ...
May 5 (Reuters) - Spero Therapeutics Inc: * SPERO THERAPEUTICS COMPLETES PATIENT ENROLLMENT IN PIVOTAL PHASE 3 CLINICAL TRIAL OF ORAL TEBIPENEM HBR VERSUS INTRAVENOUS ERTAPENEM FOR THE TREATMENT OF ...
FDA Approves New Indication for INVANZ (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck ...
Results showed that sulopenem failed to demonstrate non-inferiority to ertapenem (difference of 4.7%; 95% CI: -10.3, 1.0); 85.5% of patients in the sulopenem arm had a clinical response vs 90.2% of ...
Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales. Oral tebipenem pivoxil hydrobromide (HBr), a carbapenem, is as effective as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results